PROFILPELAJAR.COM

NMRA-511

NMRA-511
Clinical data
Other namesNMRA511; BTRX-323511; BTRX323511; NMRA-323511; NMRA323511
Drug classVasopressin V1A receptor antagonist

NMRA-511, also known as BTRX-323511 or NMRA-323511, is a vasopressin V1A receptor antagonist which is under development for the treatment of agitation and anxiety disorders.[1][2][3][4] It has been found to reduce threat behaviors in marmosets.[4] The drug was originated by BlackThorn Therapeutics and is under development by Neumora Therapeutics.[1][2][3] As of April 2026, it is in phase 1 clinical trials for agitation, whereas no decent development has been reported for anxiety disorders.[1] The chemical structure of NMRA-511 does not yet appear to have been disclosed.[1][3]

See also

References

  1. ^ a b c d "NMRA 511". AdisInsight. 10 April 2026. Retrieved 2 June 2026.
  2. ^ a b "Delving into the Latest Updates on NMRA-511 with Synapse". Synapse. 19 March 2026. Retrieved 2 June 2026.
  3. ^ a b c Baska F, Bozó É, Patócs T (2023). "Vasopressin receptor antagonists: a patent summary (2018-2022)". Expert Opinion on Therapeutic Patents. 33 (5): 385–395. doi:10.1080/13543776.2023.2218546. PMID 37226495. BlackThorn Therapeutics has also investigated selective V1a receptor antagonists for the treatment of social and emotional disabilities. They prioritized the scaffold hopping approach during their research and modified the well-known benzodiazepine and benzazepine structures [61–63]. These attempts resulted in BTRX-323511, but after the merge with Neumora Therapeutics, the compound was further developed as NMRA511 (its structure has not yet been disclosed) [97].
  4. ^ a b Wallace, T., Morrison, F., Gerrard, P., Ereshefsky, L., Ballard, M., Posener, J., ... & Tiller, J (December 2022). "NMRA-511, a Novel Vasopressin 1a (V1a) Receptor Antagonist Reduces Threat Behaviors in Marmosets and Alters EEG Power Spectra Similarly in Marmosets and Humans". Neuropsychopharmacology. 47 (Suppl 1): 334.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by adding missing information.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.